London: Pfizer and BioNTech said a late-stage trial of their experimental mRNA vaccine to protect against influensa and COVID-19 found the combination shot failed to meet one of the study's two main ...
New Delhi: Clinical trials of an mRNA vaccine have begun and researchers expect broadly positive outcomes in the battle against the widespread illness. Influensa kills up to 650,000 people around the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results